This is a Validated Antibody Database (VAD) review about human CD80, based on 116 published articles (read how Labome selects the articles), using CD80 antibody in all methods. It is aimed to help Labome visitors find the most suited CD80 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD80 synonym: B7; B7-1; B7.1; BB1; CD28LG; CD28LG1; LAB7

BioLegend
mouse monoclonal (2D10)
  • flow cytometry; mouse; 1:100; fig 1k
BioLegend CD80 antibody (Biolegend, 305221) was used in flow cytometry on mouse samples at 1:100 (fig 1k). Nat Commun (2021) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 3s2b
BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples (fig 3s2b). elife (2020) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig s1c
BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples (fig s1c). BMC Cancer (2020) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 4s2a
BioLegend CD80 antibody (Biolegend, 305225) was used in flow cytometry on human samples (fig 4s2a). elife (2020) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; 1:100; loading ...; fig s20c
BioLegend CD80 antibody (Biolegend, 305222) was used in flow cytometry on human samples at 1:100 (fig s20c). Nat Commun (2020) ncbi
mouse monoclonal (2D10)
  • mass cytometry; human; 0.5 mg/ml; loading ...; fig s11a
BioLegend CD80 antibody (Biolegend, 2D10) was used in mass cytometry on human samples at 0.5 mg/ml (fig s11a). Nature (2020) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; 1 ug/ml; loading ...; fig s3a
BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples at 1 ug/ml (fig s3a). Science (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 6b
BioLegend CD80 antibody (Biolegend, 305222) was used in flow cytometry on human samples (fig 6b). Cell Rep (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 5b
BioLegend CD80 antibody (Biolegend, 305220) was used in flow cytometry on human samples (fig 5b). elife (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 3c
BioLegend CD80 antibody (Biolegend, 305221) was used in flow cytometry on human samples (fig 3c). Cell Rep (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig 3b
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 3b). Sci Rep (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 4e
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 4e). Nat Med (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; 1:50; loading ...; fig s6a
BioLegend CD80 antibody (BioLegend, 305220) was used in flow cytometry on human samples at 1:50 (fig s6a). Nat Commun (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 1b). BMC Immunol (2019) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 1b). Front Immunol (2018) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 6f
BioLegend CD80 antibody (Biolegend, 305218) was used in flow cytometry on human samples (fig 6f). Ann Rheum Dis (2018) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig s1b
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig s1b). Mol Biol Cell (2018) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 2b
In order to study the involvement of RANKL in decidual M2 macrophage polarization, BioLegend CD80 antibody (Biolegend, 305218) was used in flow cytometry on human samples (fig 2b). Cell Death Dis (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 2a
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 2a). J Immunol (2017) ncbi
mouse monoclonal (2D10)
  • mass cytometry; human; loading ...; fig 2a
In order to investigate the immune composition of tumor microenvironment in hepatocellular carcinoma, BioLegend CD80 antibody (BioLegend, 2D10) was used in mass cytometry on human samples (fig 2a). Proc Natl Acad Sci U S A (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 5b
In order to map the lineage of human dendritic cells, BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 5b). Science (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig s6a
In order to investigate the involvement of the TRIF pathway against the infection of Zika, Chikungunya, and Dengue viruses, BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig s6a). MBio (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; 1:50; loading ...; fig s1d
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples at 1:50 (fig s1d). Nat Commun (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 4a
BioLegend CD80 antibody (BioLegend, 305207) was used in flow cytometry on human samples (fig 4a). Oncoimmunology (2016) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 1b
In order to investigate the roles of CD16+ monocytes in T-cell activation and B-cell responses in systemic lupus erythematosus, BioLegend CD80 antibody (Biolegend, 305221) was used in flow cytometry on human samples (fig 1b). Front Immunol (2016) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 2b
BioLegend CD80 antibody (BioLegend, 305206) was used in flow cytometry on human samples (fig 2b). Oncogene (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig 1a
BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples (fig 1a). Sci Rep (2016) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; tbl 1
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (tbl 1). J Immunol (2016) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig s6b
In order to test if AML patients treated decitabine have induced expression of cancer testis antigens, BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig s6b). Oncotarget (2016) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig 1
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 1). J Immunol Methods (2016) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 1b
BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples (fig 1b). J Immunol Res (2015) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig 3
In order to study human cord blood and bone marrow for restricted dendritic cell and monocyte progenitors, BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples (fig 3). J Exp Med (2015) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human
BioLegend CD80 antibody (Biolegend, 305217) was used in flow cytometry on human samples . Tissue Eng Part A (2015) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig 4
BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples (fig 4). Toxicol Sci (2015) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human
In order to determine the presence, frequency, association to other immune parameters, and functional properties of circulating CD14(+) cells lacking HLA-DR expression in patients with untreated chronic lymphocytic leukemia, BioLegend CD80 antibody (Biolegend, 2D10) was used in flow cytometry on human samples . Blood (2014) ncbi
mouse monoclonal (2D10)
  • flow cytometry; mouse
BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on mouse samples . PLoS ONE (2014) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 4b
In order to test if hip fracture and depressive symptoms had additive effects upon the aged immune system, BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 4b). Exp Gerontol (2014) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 2a
In order to assess how different concentrations of IFN-gamma affect dendritic cells, BioLegend CD80 antibody (BioLegend, 2D10) was used in flow cytometry on human samples (fig 2a). J Leukoc Biol (2014) ncbi
Invitrogen
mouse monoclonal (MEM-233)
  • flow cytometry; human; loading ...; fig 1a
In order to measure CD80 and CD86 expression on CD14+HLA-DR+ monocytes from patients with Chagas disease, Invitrogen CD80 antibody (Invitrogen, MA1-10288) was used in flow cytometry on human samples (fig 1a). Rev Soc Bras Med Trop (2016) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; tbl 1
In order to research adipose tissue-derived mesenchymal stem cell proliferation and death with oxysterols, Invitrogen CD80 antibody (Invitrogen, MHCD8001- FITC) was used in flow cytometry on human samples (tbl 1). J Steroid Biochem Mol Biol (2017) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to learn about stoichiometry of membrane proteins by single-molecule localization microscopy, Invitrogen CD80 antibody (Life Technologies, MEM-233) was used in flow cytometry on human samples . Sci Rep (2015) ncbi
mouse monoclonal (2D10.4)
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscience, 2D10.4) was used in flow cytometry on human samples . PLoS Negl Trop Dis (2014) ncbi
mouse monoclonal (2D10.4)
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscience, 2D10.4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (2D10.4)
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscence, 2D10.4) was used in flow cytometry on human samples . J Immunol (2014) ncbi
mouse monoclonal (2D10.4)
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscience, 2D10.4) was used in flow cytometry on human samples . Immunology (2015) ncbi
mouse monoclonal (2D10.4)
  • flow cytometry; human
Invitrogen CD80 antibody (eBioscience, 2D10.4) was used in flow cytometry on human samples . Clin Exp Immunol (2014) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to assess the susceptibility of fetal membranes-derived mesenchymal stromal/stem cells to all members of the human Herpesviridae family, Invitrogen CD80 antibody (Caltag Laboratories, clone EM-233) was used in flow cytometry on human samples . PLoS ONE (2013) ncbi
mouse monoclonal (2D10.4)
  • flow cytometry; human
In order to assess the effects of beraprost treatment on B cells, Invitrogen CD80 antibody (Biosource, 2D10) was used in flow cytometry on human samples . J Immunol (2011) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; fig 1
In order to test if activation of monocytes via FcgammaR induced cell differentiation, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples (fig 1). J Immunol (2009) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; fig 3
In order to identify and characterize a signal transduction cascade in monocytes that results in their differentiation into dendritic cells, Invitrogen CD80 antibody (Caltag, MEM233) was used in flow cytometry on human samples (fig 3). J Immunol (2008) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; fig 4
In order to test if leukocyte Ig-like receptor A2 regulates DC differentiation using a leprosy model, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples (fig 4). J Immunol (2007) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; African green monkey
In order to utilize single color flow cytometry test to reactivity of 204 monoclonal antibodies against human cell surface molecules in Aotus nancymaae splenocytes, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on African green monkey samples . Vet Immunol Immunopathol (2007) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to indicate that type 1 interferon-beta promotes the expansion and function of invariant natural killer cells for multiple sclerosis and type 1 diabetes treatment, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples . Immunology (2007) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; tbl 1
In order to characterize B cells in human tonsils, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples (tbl 1). Blood (2007) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; tbl 2
  • immunocytochemistry; human; fig 2d
In order to compare X-L of Mac -1 with other neutrophil activators, Invitrogen CD80 antibody (Caltag, MEM233) was used in flow cytometry on human samples (tbl 2) and in immunocytochemistry on human samples (fig 2d). Immunology (2006) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to characterize dendritic cells in type 1 and type 2 diabetes, Invitrogen CD80 antibody (Caltag, MEM233) was used in flow cytometry on human samples . Clin Immunol (2006) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to use flow cytometry to characterize mesenchymal stromal cell subsets and abnormalities, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples . Haematologica (2006) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; tbl 1
In order to compare the immunogenic properties of human adipose tissue-derived stromal vascular fraction cells to adipose-derived stem cells, Invitrogen CD80 antibody (Caltag, MHCD8001) was used in flow cytometry on human samples (tbl 1). Stem Cells (2006) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to test if transfer of allogeneic material to T cells modifies human alloresponses, Invitrogen CD80 antibody (Caltag, MEM233) was used in flow cytometry on human samples . Am J Transplant (2005) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to test if different professional antigen presenting cells express different mRNA TLR transcripts, Invitrogen CD80 antibody (Caltag, MHCD8001) was used in flow cytometry on human samples . Mol Immunol (2005) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; fig 6
In order to investigate how neutrophils present antigen, Invitrogen CD80 antibody (Caltag, MEM 233) was used in flow cytometry on human samples (fig 6). Immunology (2005) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
In order to report that OX40 ligand is selectively induced by IL-2, IL-12, or IL-15-activated human NK cells following stimulation through NKG2D, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples . J Immunol (2004) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human; fig 1
In order to elucidate the importance of C domains in the functioning of CD80 and CD86, Invitrogen CD80 antibody (Caltag, MEM-233) was used in flow cytometry on human samples (fig 1). Int Immunol (2003) ncbi
Abcam
domestic rabbit monoclonal (EPR1157(2))
  • immunohistochemistry - paraffin section; human; loading ...; fig 6d
Abcam CD80 antibody (Abcam, ab134120) was used in immunohistochemistry - paraffin section on human samples (fig 6d). Mol Cancer (2021) ncbi
domestic rabbit monoclonal (EPR1157(2))
  • immunohistochemistry - paraffin section; human; loading ...; fig s7d
Abcam CD80 antibody (Abcam, ab134120) was used in immunohistochemistry - paraffin section on human samples (fig s7d). Cell (2019) ncbi
mouse monoclonal (MEM-233)
  • flow cytometry; human
Abcam CD80 antibody (Abcam, ab8239) was used in flow cytometry on human samples . Int J Mol Sci (2014) ncbi
domestic rabbit monoclonal (EPR1157(2))
  • immunohistochemistry - paraffin section; human; 1:100
Abcam CD80 antibody (Abcam, ab134120) was used in immunohistochemistry - paraffin section on human samples at 1:100. Int J Cardiol (2014) ncbi
Miltenyi Biotec
mouse monoclonal (2D10)
  • flow cytometry; human; loading ...; fig 1a
In order to develop a recombinant Saccharomyces cerevisiae as a vehicle to deliver genes to primary human macrophages, Miltenyi Biotec CD80 antibody (Miltenyi Biotec, 2D10) was used in flow cytometry on human samples (fig 1a). Eur J Pharm Biopharm (2017) ncbi
mouse monoclonal (2D10)
  • flow cytometry; human; fig 1
In order to analyze how Saccharomyces cerevisiae interacts with different macrophage subsets, Miltenyi Biotec CD80 antibody (Miltenyi Biotec, 2D10) was used in flow cytometry on human samples (fig 1). Inflammation (2016) ncbi
Bio-Rad
mouse monoclonal (MEM-233)
  • flow cytometry; human
Bio-Rad CD80 antibody (AbD Serotec, MEM-233) was used in flow cytometry on human samples . Front Immunol (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (2D10)
  • flow cytometry; human; 1:10; fig 3
Santa Cruz Biotechnology CD80 antibody (Santa Cruz, sc-73382) was used in flow cytometry on human samples at 1:10 (fig 3). Mol Med Rep (2016) ncbi
Beckman Coulter
mouse monoclonal (MAB104)
  • flow cytometry; human
Beckman Coulter CD80 antibody (Beckman Coulter, MAB104) was used in flow cytometry on human samples . J Immunol Res (2014) ncbi
BD Biosciences
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 2c, 4b
BD Biosciences CD80 antibody (BD, L307.4) was used in flow cytometry on human samples (fig 2c, 4b). Rheumatology (Oxford) (2020) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD80 antibody (BD, L307.4) was used in flow cytometry on human samples (fig 1a). Front Immunol (2018) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 3e
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig 3e). Proc Natl Acad Sci U S A (2019) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig s4a
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig s4a). Cancer (2019) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 3f
BD Biosciences CD80 antibody (BD, 563084) was used in flow cytometry on human samples (fig 3f). J Clin Invest (2018) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig 4a
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig 4a). Front Immunol (2017) ncbi
mouse monoclonal (L307.4)
  • mass cytometry; human; loading ...; fig s3a
In order to map the lineage of human dendritic cells, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in mass cytometry on human samples (fig s3a). Science (2017) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig 5a
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences CD80 antibody (Becton Dickinson, L307.4) was used in flow cytometry on human samples (fig 5a). J Leukoc Biol (2017) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; tbl 3
In order to document and describe lymphocyte predominant cells from lymph nodes involved in nodular lymphocyte predominant Hodgkin lymphoma, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (tbl 3). Am J Pathol (2017) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig s9a
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig s9a). PLoS Pathog (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 2b
In order to assess the effects of sialic acid blockade on dendritic cells, BD Biosciences CD80 antibody (BD Bioscience, L307.4) was used in flow cytometry on human samples (fig 2b). Immunol Cell Biol (2017) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 7a
In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig 7a). PLoS ONE (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig s4j
In order to evaluate combinations of TLR and C-type lectin receptor agonists on the Th1 responses of newborn dendritic cells, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig s4j). J Immunol (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; tbl 3
BD Biosciences CD80 antibody (BD Pharmingen, L307.4) was used in flow cytometry on human samples (tbl 3). Brain Behav (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig 5
In order to investigate the impact of CD1c positive dendritic cells on immunogenic cell death, BD Biosciences CD80 antibody (BD PharMingen, 561135) was used in flow cytometry on human samples (fig 5). Oncoimmunology (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...
BD Biosciences CD80 antibody (BD, L307.4) was used in flow cytometry on human samples . J Exp Med (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig 2B
BD Biosciences CD80 antibody (BD, 560442) was used in flow cytometry on human samples (fig 2B). Reproduction (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig 1a). J Immunol (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; African green monkey; loading ...; fig 2b
In order to discuss the use of flow cytometry to examine common marmosets, BD Biosciences CD80 antibody (BD, L307.4) was used in flow cytometry on African green monkey samples (fig 2b). J Med Primatol (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; 1:200; loading ...; fig 7g
In order to find that coagulation factor XII modulates immune responses, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples at 1:200 (fig 7g). Nat Commun (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; 1:20; tbl 2
BD Biosciences CD80 antibody (BD PharMingen, 560442) was used in flow cytometry on human samples at 1:20 (tbl 2). Oncoimmunology (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig st1
In order to find cell-surface markers specific to human neutrophils, BD Biosciences CD80 antibody (BD, 557227) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig st1
In order to discuss the impact of filaggrin mutations on the development of atopic dermatitis, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples (fig st1). J Allergy Clin Immunol (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 7c
BD Biosciences CD80 antibody (BD Bioscience, L307.4) was used in flow cytometry on human samples (fig 7c). PLoS ONE (2016) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 2a
BD Biosciences CD80 antibody (BD Pharmingen, 560926) was used in flow cytometry on human samples (fig 2a). Mol Med Rep (2016) ncbi
mouse monoclonal (BB1)
  • flow cytometry; human; loading ...; fig s2
BD Biosciences CD80 antibody (BD Biosciences, BB1) was used in flow cytometry on human samples (fig s2). Sci Transl Med (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig 1
In order to study B cells migration in vivo, BD Biosciences CD80 antibody (BD Biosciences, 557226) was used in flow cytometry on human samples (fig 1). Oncoimmunology (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; fig 1
BD Biosciences CD80 antibody (BD Biosciences, 560925) was used in flow cytometry on human samples (fig 1). Mol Med Rep (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
BD Biosciences CD80 antibody (Pharmingen, 557227) was used in flow cytometry on human samples . Springerplus (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples . Immun Inflamm Dis (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; tbl 1
BD Biosciences CD80 antibody (BD Biosciences, 557227) was used in flow cytometry on human samples (tbl 1). Exp Ther Med (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
In order to discuss how inflammation contributes to pulmonary arterial hypertension, BD Biosciences CD80 antibody (BD Pharmingen, clone L307.4) was used in flow cytometry on human samples . Chest (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; rhesus macaque
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on rhesus macaque samples . J Leukoc Biol (2015) ncbi
mouse monoclonal (BB1)
  • immunohistochemistry - paraffin section; human; 1:100
BD Biosciences CD80 antibody (BD Biosciences, 555683) was used in immunohistochemistry - paraffin section on human samples at 1:100. Mol Med Rep (2015) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human; loading ...; fig 5
In order to study the immune effects of tadalafil in patients with head and neck squamous cell carcinoma., BD Biosciences CD80 antibody (BD, L307.4) was used in flow cytometry on human samples (fig 5). Clin Cancer Res (2015) ncbi
mouse monoclonal (L307.4)
  • immunocytochemistry; human
In order to study the role of dendritic cells in relation to T cells, BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in immunocytochemistry on human samples . J Immunol (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; African green monkey; fig 2
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on African green monkey samples (fig 2). PLoS Pathog (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples . PLoS ONE (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
BD Biosciences CD80 antibody (BD Biosciences, L307.4) was used in flow cytometry on human samples . Mol Immunol (2014) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; human
In order to discuss the use of PPR ligands as adjuvants and the use of interferon-gamma release assays as a diagnostic tool, BD Biosciences CD80 antibody (BD, 560925) was used in flow cytometry on human samples . PLoS ONE (2012) ncbi
mouse monoclonal (L307.4)
  • flow cytometry; South American squirrel monkey
In order to discuss available reagents for studying the neotropical primate squirrel monkey, BD Biosciences CD80 antibody (BDIS, L307.4) was used in flow cytometry on South American squirrel monkey samples . J Immunol Methods (2005) ncbi
Articles Reviewed
  1. Yan C, Saleh N, Yang J, Nebhan C, Vilgelm A, Reddy E, et al. Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade. Mol Cancer. 2021;20:85 pubmed publisher
  2. Arenas E, Martínez Sabadell A, Rius Ruiz I, Román Alonso M, Escorihuela M, Luque A, et al. Acquired cancer cell resistance to T cell bispecific antibodies and CAR T targeting HER2 through JAK2 down-modulation. Nat Commun. 2021;12:1237 pubmed publisher
  3. Gregorova M, Morse D, Brignoli T, Steventon J, Hamilton F, Albur M, et al. Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. elife. 2020;9: pubmed publisher
  4. Morrissey M, Byrne R, Nulty C, McCabe N, Lynam Lennon N, Butler C, et al. The tumour microenvironment of the upper and lower gastrointestinal tract differentially influences dendritic cell maturation. BMC Cancer. 2020;20:566 pubmed publisher
  5. Pallikkuth S, Chaudhury S, Lu P, Pan L, Jongert E, Wille Reece U, et al. A delayed fractionated dose RTS,S AS01 vaccine regimen mediates protection via improved T follicular helper and B cell responses. elife. 2020;9: pubmed publisher
  6. Kim J, Jeong J, Jung J, Jeon H, Lee S, Lim J, et al. Immunological characteristics and possible pathogenic role of urinary CD11c+ macrophages in lupus nephritis. Rheumatology (Oxford). 2020;: pubmed publisher
  7. Mosaheb M, Dobrikova E, Brown M, Yang Y, Cable J, Okada H, et al. Genetically stable poliovirus vectors activate dendritic cells and prime antitumor CD8 T cell immunity. Nat Commun. 2020;11:524 pubmed publisher
  8. Helmink B, Reddy S, Gao J, Zhang S, Basar R, Thakur R, et al. B cells and tertiary lymphoid structures promote immunotherapy response. Nature. 2020;577:549-555 pubmed publisher
  9. Le Nours J, Gherardin N, Ramarathinam S, Awad W, Wiede F, Gully B, et al. A class of γδ T cell receptors recognize the underside of the antigen-presenting molecule MR1. Science. 2019;366:1522-1527 pubmed publisher
  10. Leylek R, Alcántara Hernández M, Lanzar Z, Lüdtke A, Perez O, Reizis B, et al. Integrated Cross-Species Analysis Identifies a Conserved Transitional Dendritic Cell Population. Cell Rep. 2019;29:3736-3750.e8 pubmed publisher
  11. Zhang Q, He Y, Luo N, Patel S, Han Y, Gao R, et al. Landscape and Dynamics of Single Immune Cells in Hepatocellular Carcinoma. Cell. 2019;179:829-845.e20 pubmed publisher
  12. Pech M, Fong L, Villalta J, Chan L, Kharbanda S, O Brien J, et al. Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance. elife. 2019;8: pubmed publisher
  13. Celis Gutierrez J, Blattmann P, Zhai Y, Jarmuzynski N, Ruminski K, Gregoire C, et al. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Cell Rep. 2019;27:3315-3330.e7 pubmed publisher
  14. Humeniuk P, Geiselhart S, Battin C, Webb T, Steinberger P, Paster W, et al. Generation of a Jurkat-based fluorescent reporter cell line to evaluate lipid antigen interaction with the human iNKT cell receptor. Sci Rep. 2019;9:7426 pubmed publisher
  15. Hammerich L, Marron T, Upadhyay R, Svensson Arvelund J, Dhainaut M, Hussein S, et al. Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination. Nat Med. 2019;25:814-824 pubmed publisher
  16. Frank A, Ebersberger S, Fink A, Lampe S, Weigert A, Schmid T, et al. Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype. Nat Commun. 2019;10:1135 pubmed publisher
  17. Tremblay McLean A, Coenraads S, Kiani Z, Dupuy F, Bernard N. Expression of ligands for activating natural killer cell receptors on cell lines commonly used to assess natural killer cell function. BMC Immunol. 2019;20:8 pubmed publisher
  18. Alam M, Yang D, Trivett A, Meyer T, Oppenheim J. HMGN1 and R848 Synergistically Activate Dendritic Cells Using Multiple Signaling Pathways. Front Immunol. 2018;9:2982 pubmed publisher
  19. Ha D, Tanaka A, Kibayashi T, Tanemura A, Sugiyama D, Wing J, et al. Differential control of human Treg and effector T cells in tumor immunity by Fc-engineered anti-CTLA-4 antibody. Proc Natl Acad Sci U S A. 2019;116:609-618 pubmed publisher
  20. Richardson J, Armbruster N, Günter M, Henes J, Autenrieth S. Staphylococcus aureus PSM Peptides Modulate Human Monocyte-Derived Dendritic Cells to Prime Regulatory T Cells. Front Immunol. 2018;9:2603 pubmed publisher
  21. Williams P, Basu S, Garcia Manero G, Hourigan C, Oetjen K, Cortes J, et al. The distribution of T-cell subsets and the expression of immune checkpoint receptors and ligands in patients with newly diagnosed and relapsed acute myeloid leukemia. Cancer. 2019;125:1470-1481 pubmed publisher
  22. Burton A, Pallett L, McCoy L, Suveizdyte K, Amin O, Swadling L, et al. Circulating and intrahepatic antiviral B cells are defective in hepatitis B. J Clin Invest. 2018;128:4588-4603 pubmed publisher
  23. Sarkar M, Hile G, Tsoi L, Xing X, Liu J, Liang Y, et al. Photosensitivity and type I IFN responses in cutaneous lupus are driven by epidermal-derived interferon kappa. Ann Rheum Dis. 2018;77:1653-1664 pubmed publisher
  24. Redka D, Gutschow M, Grinstein S, Canton J. Differential ability of proinflammatory and anti-inflammatory macrophages to perform macropinocytosis. Mol Biol Cell. 2018;29:53-65 pubmed publisher
  25. Jeong J, Hong S, Kwon O, Ghang B, Hwang I, Kim Y, et al. CD14+ Cells with the Phenotype of Infiltrated Monocytes Consist of Distinct Populations Characterized by Anti-inflammatory as well as Pro-inflammatory Activity in Gouty Arthritis. Front Immunol. 2017;8:1260 pubmed publisher
  26. Meng Y, Zhou W, Jin L, Liu L, Chang K, Mei J, et al. RANKL-mediated harmonious dialogue between fetus and mother guarantees smooth gestation by inducing decidual M2 macrophage polarization. Cell Death Dis. 2017;8:e3105 pubmed publisher
  27. Salio M, Gasser O, González López C, Martens A, Veerapen N, Gileadi U, et al. Activation of Human Mucosal-Associated Invariant T Cells Induces CD40L-Dependent Maturation of Monocyte-Derived and Primary Dendritic Cells. J Immunol. 2017;199:2631-2638 pubmed publisher
  28. Chew V, Lai L, Pan L, Lim C, Li J, Ong R, et al. Delineation of an immunosuppressive gradient in hepatocellular carcinoma using high-dimensional proteomic and transcriptomic analyses. Proc Natl Acad Sci U S A. 2017;114:E5900-E5909 pubmed publisher
  29. See P, Dutertre C, Chen J, Günther P, McGovern N, Irac S, et al. Mapping the human DC lineage through the integration of high-dimensional techniques. Science. 2017;356: pubmed publisher
  30. Pryke K, Abraham J, Sali T, Gall B, Archer I, Liu A, et al. A Novel Agonist of the TRIF Pathway Induces a Cellular State Refractory to Replication of Zika, Chikungunya, and Dengue Viruses. MBio. 2017;8: pubmed publisher
  31. Seif M, Hoppstädter J, Breinig F, Kiemer A. Yeast-mediated mRNA delivery polarizes immuno-suppressive macrophages towards an immuno-stimulatory phenotype. Eur J Pharm Biopharm. 2017;117:1-13 pubmed publisher
  32. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  33. Smith N, Pietrancosta N, Davidson S, Dutrieux J, Chauveau L, Cutolo P, et al. Natural amines inhibit activation of human plasmacytoid dendritic cells through CXCR4 engagement. Nat Commun. 2017;8:14253 pubmed publisher
  34. Parrot T, Oger R, Benlalam H, Raingeard de la Blétière D, Jouand N, Coutolleau A, et al. CD40L confers helper functions to human intra-melanoma class-I-restricted CD4+CD8+ double positive T cells. Oncoimmunology. 2016;5:e1250991 pubmed publisher
  35. Fromm J, Thomas A, Wood B. Characterization and Purification of Neoplastic Cells of Nodular Lymphocyte Predominant Hodgkin Lymphoma from Lymph Nodes by Flow Cytometry and Flow Cytometric Cell Sorting. Am J Pathol. 2017;187:304-317 pubmed publisher
  36. Zhu H, Hu F, Sun X, Zhang X, Zhu L, Liu X, et al. CD16+ Monocyte Subset Was Enriched and Functionally Exacerbated in Driving T-Cell Activation and B-Cell Response in Systemic Lupus Erythematosus. Front Immunol. 2016;7:512 pubmed
  37. Tomic A, Varanasi P, Golemac M, Malic S, Riese P, Borst E, et al. Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand. PLoS Pathog. 2016;12:e1006015 pubmed publisher
  38. Bull C, Collado Camps E, Kers Rebel E, Heise T, Søndergaard J, den Brok M, et al. Metabolic sialic acid blockade lowers the activation threshold of moDCs for TLR stimulation. Immunol Cell Biol. 2017;95:408-415 pubmed publisher
  39. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed publisher
  40. Soares A, Neves P, Cavalcanti M, Marinho S, Oliveira W, Souza J, et al. Expression of co-stimulatory molecules CD80 and CD86 is altered in CD14 + HLA-DR + monocytes from patients with Chagas disease following induction by Trypanosoma cruzi recombinant antigens. Rev Soc Bras Med Trop. 2016;49:632-636 pubmed publisher
  41. van Haren S, Dowling D, Foppen W, Christensen D, Andersen P, Reed S, et al. Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization. J Immunol. 2016;197:4413-4424 pubmed
  42. Dyer W, Tan J, Day T, Kiers L, Kiernan M, Yiannikas C, et al. Immunomodulation of inflammatory leukocyte markers during intravenous immunoglobulin treatment associated with clinical efficacy in chronic inflammatory demyelinating polyradiculoneuropathy. Brain Behav. 2016;6:e00516 pubmed
  43. Di Blasio S, Wortel I, van Bladel D, de Vries L, Duiveman de Boer T, Worah K, et al. Human CD1c(+) DCs are critical cellular mediators of immune responses induced by immunogenic cell death. Oncoimmunology. 2016;5:e1192739 pubmed publisher
  44. Tagawa T, Albanese M, Bouvet M, Moosmann A, Mautner J, Heissmeyer V, et al. Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med. 2016;213:2065-80 pubmed publisher
  45. Deng Y, Cheng J, Fu B, Liu W, Chen G, Zhang Q, et al. Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells. Oncogene. 2017;36:1090-1101 pubmed publisher
  46. Rosskopf S, Jutz S, Neunkirchner A, Candia M, Jahn Schmid B, Bohle B, et al. Creation of an engineered APC system to explore and optimize the presentation of immunodominant peptides of major allergens. Sci Rep. 2016;6:31580 pubmed publisher
  47. Loegl J, Hiden U, Nussbaumer E, Schliefsteiner C, Cvitic S, Lang I, et al. Hofbauer cells of M2a, M2b and M2c polarization may regulate feto-placental angiogenesis. Reproduction. 2016;152:447-55 pubmed publisher
  48. Seif M, Philippi A, Breinig F, Kiemer A, Hoppstädter J. Yeast (Saccharomyces cerevisiae) Polarizes Both M-CSF- and GM-CSF-Differentiated Macrophages Toward an M1-Like Phenotype. Inflammation. 2016;39:1690-703 pubmed publisher
  49. Loyon R, Picard E, Mauvais O, Queiroz L, Mougey V, Pallandre J, et al. IL-21-Induced MHC Class II+ NK Cells Promote the Expansion of Human Uncommitted CD4+ Central Memory T Cells in a Macrophage Migration Inhibitory Factor-Dependent Manner. J Immunol. 2016;197:85-96 pubmed publisher
  50. Neumann B, Shi T, Gan L, Klippert A, Daskalaki M, Stolte Leeb N, et al. Comprehensive panel of cross-reacting monoclonal antibodies for analysis of different immune cells and their distribution in the common marmoset (Callithrix jacchus). J Med Primatol. 2016;45:139-46 pubmed publisher
  51. Göbel K, Pankratz S, Asaridou C, Herrmann A, Bittner S, Merker M, et al. Blood coagulation factor XII drives adaptive immunity during neuroinflammation via CD87-mediated modulation of dendritic cells. Nat Commun. 2016;7:11626 pubmed publisher
  52. Cook A, McDonnell A, Lake R, Nowak A. Dexamethasone co-medication in cancer patients undergoing chemotherapy causes substantial immunomodulatory effects with implications for chemo-immunotherapy strategies. Oncoimmunology. 2016;5:e1066062 pubmed
  53. Silva S, Levy D, Ruiz J, de Melo T, Isaac C, Fidelis M, et al. Oxysterols in adipose tissue-derived mesenchymal stem cell proliferation and death. J Steroid Biochem Mol Biol. 2017;169:164-175 pubmed publisher
  54. Li H, Borrego F, Nagata S, Tolnay M. Fc Receptor-like 5 Expression Distinguishes Two Distinct Subsets of Human Circulating Tissue-like Memory B Cells. J Immunol. 2016;196:4064-74 pubmed publisher
  55. Lin R, Zhang J, Zhou L, Wang B. Altered function of monocytes/macrophages in patients with autoimmune hepatitis. Mol Med Rep. 2016;13:3874-80 pubmed publisher
  56. Lakschevitz F, Hassanpour S, Rubin A, Fine N, Sun C, Glogauer M. Identification of neutrophil surface marker changes in health and inflammation using high-throughput screening flow cytometry. Exp Cell Res. 2016;342:200-9 pubmed publisher
  57. Leitch C, Natafji E, Yu C, Abdul Ghaffar S, Madarasingha N, Venables Z, et al. Filaggrin-null mutations are associated with increased maturation markers on Langerhans cells. J Allergy Clin Immunol. 2016;138:482-490.e7 pubmed publisher
  58. Srivastava P, Paluch B, Matsuzaki J, James S, Collamat Lai G, Blagitko Dorfs N, et al. Induction of cancer testis antigen expression in circulating acute myeloid leukemia blasts following hypomethylating agent monotherapy. Oncotarget. 2016;7:12840-56 pubmed publisher
  59. Gupta S, Termini J, Issac B, Guirado E, Stone G. Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors. PLoS ONE. 2016;11:e0148929 pubmed publisher
  60. Jutz S, Leitner J, Schmetterer K, Doel Perez I, Majdic O, Grabmeier Pfistershammer K, et al. Assessment of costimulation and coinhibition in a triple parameter T cell reporter line: Simultaneous measurement of NF-κB, NFAT and AP-1. J Immunol Methods. 2016;430:10-20 pubmed publisher
  61. Wang H, Feng F, Wang X, Wang R, Wu Y, Zhu M, et al. Dendritic cells pulsed with Hsp70 and HBxAg induce specific antitumor immune responses in hepatitis B virus-associated hepatocellular carcinoma. Mol Med Rep. 2016;13:1077-82 pubmed publisher
  62. Li R, Rezk A, Miyazaki Y, Hilgenberg E, Touil H, Shen P, et al. Proinflammatory GM-CSF-producing B cells in multiple sclerosis and B cell depletion therapy. Sci Transl Med. 2015;7:310ra166 pubmed publisher
  63. Gonzalez N, Wennhold K, Balkow S, Kondo E, Bölck B, Weber T, et al. In vitro and in vivo imaging of initial B-T-cell interactions in the setting of B-cell based cancer immunotherapy. Oncoimmunology. 2015;4:e1038684 pubmed
  64. Fricke F, Beaudouin J, Eils R, Heilemann M. One, two or three? Probing the stoichiometry of membrane proteins by single-molecule localization microscopy. Sci Rep. 2015;5:14072 pubmed publisher
  65. Iwabuchi M, Narita M, Uchiyama T, Iwaya S, Oiwa E, Nishizawa Y, et al. Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene. Mol Med Rep. 2015;12:2443-50 pubmed publisher
  66. Donis Maturano L, Sánchez Torres L, Cerbulo Vázquez A, Chacón Salinas R, García Romo G, Orozco Uribe M, et al. Prolonged exposure to neutrophil extracellular traps can induce mitochondrial damage in macrophages and dendritic cells. Springerplus. 2015;4:161 pubmed publisher
  67. Trabanelli S, Lecciso M, Salvestrini V, Cavo M, Očadlíková D, Lemoli R, et al. PGE2-induced IDO1 inhibits the capacity of fully mature DCs to elicit an in vitro antileukemic immune response. J Immunol Res. 2015;2015:253191 pubmed publisher
  68. Lee J, Breton G, Oliveira T, Zhou Y, Aljoufi A, PUHR S, et al. Restricted dendritic cell and monocyte progenitors in human cord blood and bone marrow. J Exp Med. 2015;212:385-99 pubmed publisher
  69. Musson D, Naot D, Chhana A, Matthews B, McIntosh J, Lin S, et al. In vitro evaluation of a novel non-mulberry silk scaffold for use in tendon regeneration. Tissue Eng Part A. 2015;21:1539-51 pubmed publisher
  70. Reiner A, Heldt S, Presley C, Guley N, Elberger A, Deng Y, et al. Motor, visual and emotional deficits in mice after closed-head mild traumatic brain injury are alleviated by the novel CB2 inverse agonist SMM-189. Int J Mol Sci. 2014;16:758-87 pubmed publisher
  71. Phadnis Moghe A, Crawford R, Kaminski N. Suppression of human B cell activation by 2,3,7,8-tetrachlorodibenzo-p-dioxin involves altered regulation of B cell lymphoma-6. Toxicol Sci. 2015;144:39-50 pubmed publisher
  72. Heninger A, Wentrup S, Al Saeedi M, Schiessling S, Giese T, Wartha F, et al. Immunomodulation of human intestinal T cells by the synthetic CD80 antagonist RhuDex®. Immun Inflamm Dis. 2014;2:166-80 pubmed publisher
  73. Wang H, Zhang L, Zhang S, Li Y. Inhibition of vascular endothelial growth factor by small interfering RNA upregulates differentiation, maturation and function of dendritic cells. Exp Ther Med. 2015;9:120-124 pubmed
  74. Hautefort A, Girerd B, Montani D, Cohen Kaminsky S, Price L, Lambrecht B, et al. T-helper 17 cell polarization in pulmonary arterial hypertension. Chest. 2015;147:1610-1620 pubmed publisher
  75. Thompson I, Mann E, Stokes M, English N, Knight S, Williamson D. Specific activation of dendritic cells enhances clearance of Bacillus anthracis following infection. PLoS ONE. 2014;9:e109720 pubmed publisher
  76. Neumann B, Klippert A, Raue K, Sopper S, Stahl Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol. 2015;97:19-30 pubmed publisher
  77. Liao S, Ding T, Rao X, Sun D, Sun P, Wang Y, et al. Cigarette smoke affects dendritic cell maturation in the small airways of patients with chronic obstructive pulmonary disease. Mol Med Rep. 2015;11:219-25 pubmed publisher
  78. Weed D, Vella J, Reis I, De La Fuente A, Gomez C, Sargi Z, et al. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma. Clin Cancer Res. 2015;21:39-48 pubmed publisher
  79. Škrnjug I, Guzmán C, Rueckert C, Ruecker C. Cyclic GMP-AMP displays mucosal adjuvant activity in mice. PLoS ONE. 2014;9:e110150 pubmed publisher
  80. O Regan N, Steinfelder S, Venugopal G, Rao G, Lucius R, Srikantam A, et al. Brugia malayi microfilariae induce a regulatory monocyte/macrophage phenotype that suppresses innate and adaptive immune responses. PLoS Negl Trop Dis. 2014;8:e3206 pubmed publisher
  81. Yu C, Becker C, Metang P, Marches F, Wang Y, Toshiyuki H, et al. Human CD141+ dendritic cells induce CD4+ T cells to produce type 2 cytokines. J Immunol. 2014;193:4335-43 pubmed publisher
  82. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  83. Royle C, Graham D, Sharma S, Fuchs D, Boasso A. HIV-1 and HIV-2 differentially mature plasmacytoid dendritic cells into IFN-producing cells or APCs. J Immunol. 2014;193:3538-48 pubmed publisher
  84. Kivisakk P, Francois K, Mbianda J, Gandhi R, Weiner H, Khoury S. Effect of natalizumab treatment on circulating plasmacytoid dendritic cells: a cross-sectional observational study in patients with multiple sclerosis. PLoS ONE. 2014;9:e103716 pubmed publisher
  85. Said A, Bock S, Müller G, Weindl G. Inflammatory conditions distinctively alter immunological functions of Langerhans-like cells and dendritic cells in vitro. Immunology. 2015;144:218-30 pubmed publisher
  86. Lee Chang C, Bodogai M, Moritoh K, Olkhanud P, Chan A, Croft M, et al. Accumulation of 4-1BBL+ B cells in the elderly induces the generation of granzyme-B+ CD8+ T cells with potential antitumor activity. Blood. 2014;124:1450-9 pubmed publisher
  87. Jacquelin B, Petitjean G, Kunkel D, Liovat A, Jochems S, Rogers K, et al. Innate immune responses and rapid control of inflammation in African green monkeys treated or not with interferon-alpha during primary SIVagm infection. PLoS Pathog. 2014;10:e1004241 pubmed publisher
  88. Gupta M, Kolli D, Molteni C, Casola A, Garofalo R. Paramyxovirus infection regulates T cell responses by BDCA-1+ and BDCA-3+ myeloid dendritic cells. PLoS ONE. 2014;9:e99227 pubmed publisher
  89. Jitschin R, Braun M, Büttner M, Dettmer Wilde K, Bricks J, Berger J, et al. CLL-cells induce IDOhi CD14+HLA-DRlo myeloid-derived suppressor cells that inhibit T-cell responses and promote TRegs. Blood. 2014;124:750-60 pubmed publisher
  90. Moreno Fernandez M, Joedicke J, Chougnet C. Regulatory T Cells Diminish HIV Infection in Dendritic Cells - Conventional CD4(+) T Cell Clusters. Front Immunol. 2014;5:199 pubmed publisher
  91. Müller A, Mu L, Meletta R, Beck K, Rancic Z, Drandarov K, et al. Towards non-invasive imaging of vulnerable atherosclerotic plaques by targeting co-stimulatory molecules. Int J Cardiol. 2014;174:503-15 pubmed publisher
  92. Skrnjug I, Rueckert C, Libanova R, Lienenklaus S, Weiss S, Guzman C. The mucosal adjuvant cyclic di-AMP exerts immune stimulatory effects on dendritic cells and macrophages. PLoS ONE. 2014;9:e95728 pubmed publisher
  93. Mao C, Mou X, Zhou Y, Yuan G, Xu C, Liu H, et al. Tumor-activated TCR??? T cells from gastric cancer patients induce the antitumor immune response of TCR??? T cells via their antigen-presenting cell-like effects. J Immunol Res. 2014;2014:593562 pubmed publisher
  94. Søndergaard J, Vinner L, Brix S. Natural mannosylation of HIV-1 gp120 imposes no immunoregulatory effects in primary human plasmacytoid dendritic cells. Mol Immunol. 2014;59:180-7 pubmed publisher
  95. Duggal N, Beswetherick A, Upton J, Hampson P, Phillips A, Lord J. Depressive symptoms in hip fracture patients are associated with reduced monocyte superoxide production. Exp Gerontol. 2014;54:27-34 pubmed publisher
  96. Zouk H, d Hennezel E, Du X, Ounissi Benkalha H, Piccirillo C, Polychronakos C. Functional evaluation of the role of C-type lectin domain family 16A at the chromosome 16p13 locus. Clin Exp Immunol. 2014;175:485-97 pubmed publisher
  97. Avanzi S, Leoni V, Rotola A, Alviano F, Solimando L, Lanzoni G, et al. Susceptibility of human placenta derived mesenchymal stromal/stem cells to human herpesviruses infection. PLoS ONE. 2013;8:e71412 pubmed publisher
  98. Svajger U, Obermajer N, Jeras M. IFN-?-rich environment programs dendritic cells toward silencing of cytotoxic immune responses. J Leukoc Biol. 2014;95:33-46 pubmed publisher
  99. Gaur R, Suhosk M, Banaei N. In vitro immunomodulation of a whole blood IFN-? release assay enhances T cell responses in subjects with latent tuberculosis infection. PLoS ONE. 2012;7:e48027 pubmed publisher
  100. Kim J, Park C, Park C, Jeoung D, Kim Y, Choe J. Beraprost enhances the APC function of B cells by upregulating CD86 expression levels. J Immunol. 2011;186:3866-73 pubmed publisher
  101. Tanaka M, Krutzik S, Sieling P, Lee D, Rea T, Modlin R. Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses. J Immunol. 2009;183:2349-55 pubmed publisher
  102. Stephens T, Nikoopour E, Rider B, Leon Ponte M, Chau T, Mikolajczak S, et al. Dendritic cell differentiation induced by a self-peptide derived from apolipoprotein E. J Immunol. 2008;181:6859-71 pubmed
  103. Lee D, Sieling P, Ochoa M, Krutzik S, Guo B, Hernandez M, et al. LILRA2 activation inhibits dendritic cell differentiation and antigen presentation to T cells. J Immunol. 2007;179:8128-36 pubmed
  104. Daubenberger C, Spirig R, Patarroyo M, Pluschke G. Flow cytometric analysis on cross-reactivity of human-specific CD monoclonal antibodies with splenocytes of Aotus nancymaae, a non-human primate model for biomedical research. Vet Immunol Immunopathol. 2007;119:14-20 pubmed
  105. Gigli G, Caielli S, Cutuli D, Falcone M. Innate immunity modulates autoimmunity: type 1 interferon-beta treatment in multiple sclerosis promotes growth and function of regulatory invariant natural killer T cells through dendritic cell maturation. Immunology. 2007;122:409-17 pubmed
  106. Kolar G, Mehta D, Pelayo R, Capra J. A novel human B cell subpopulation representing the initial germinal center population to express AID. Blood. 2007;109:2545-52 pubmed
  107. Sandilands G, McCrae J, Hill K, Perry M, Baxter D. Major histocompatibility complex class II (DR) antigen and costimulatory molecules on in vitro and in vivo activated human polymorphonuclear neutrophils. Immunology. 2006;119:562-71 pubmed
  108. Summers K, Marleau A, Mahon J, McManus R, Hramiak I, Singh B. Reduced IFN-alpha secretion by blood dendritic cells in human diabetes. Clin Immunol. 2006;121:81-9 pubmed
  109. Campioni D, Moretti S, Ferrari L, Punturieri M, Castoldi G, Lanza F. Immunophenotypic heterogeneity of bone marrow-derived mesenchymal stromal cells from patients with hematologic disorders: correlation with bone marrow microenvironment. Haematologica. 2006;91:364-8 pubmed
  110. McIntosh K, Zvonic S, Garrett S, Mitchell J, Floyd Z, Hammill L, et al. The immunogenicity of human adipose-derived cells: temporal changes in vitro. Stem Cells. 2006;24:1246-53 pubmed
  111. Game D, Rogers N, Lechler R. Acquisition of HLA-DR and costimulatory molecules by T cells from allogeneic antigen presenting cells. Am J Transplant. 2005;5:1614-25 pubmed
  112. Kokkinopoulos I, Jordan W, Ritter M. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol Immunol. 2005;42:957-68 pubmed
  113. Contamin H, Loizon S, Bourreau E, Michel J, Garraud O, Mercereau Puijalon O, et al. Flow cytometry identification and characterization of mononuclear cell subsets in the neotropical primate Saimiri sciureus (squirrel monkey). J Immunol Methods. 2005;297:61-71 pubmed
  114. Sandilands G, Ahmed Z, Perry N, Davison M, Lupton A, Young B. Cross-linking of neutrophil CD11b results in rapid cell surface expression of molecules required for antigen presentation and T-cell activation. Immunology. 2005;114:354-68 pubmed
  115. Zingoni A, Sornasse T, Cocks B, Tanaka Y, Santoni A, Lanier L. Cross-talk between activated human NK cells and CD4+ T cells via OX40-OX40 ligand interactions. J Immunol. 2004;173:3716-24 pubmed
  116. Vasu C, Wang A, Gorla S, Kaithamana S, Prabhakar B, Holterman M. CD80 and CD86 C domains play an important role in receptor binding and co-stimulatory properties. Int Immunol. 2003;15:167-75 pubmed